A press release from the Montreal Heart Institute has announced that the COLCORONA clinical trial has provided evidence of the protective effect of colchicine; demonstrating a 21% reduced risk of death or hospitalizations in patients with COVID-19 compared to placebo.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, with more than a dozen items to review on this week's podcast.
NEJM has published the interim analysis of the REGN-COV2 trial, wherein an antibody cocktail reduced viral loads with less clinical consequences.
JAMA has published the BLAZE-1 study, showing significant SARS-CoV-2 viral load reduction at day 11 and less COVID-19 progression when combination anti-spike monoclonal antibody therapy (bamlanivimab and etesevimab) was given to mild to moderate, non-hospitalized COVID-19 patients.
Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million.
The CDC has addressed the effects and the issues of domestic and international travel on its website. Below is a sampling of key advice.
2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.
Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.
Zoom has become the slam dunk answer to the pandemic. With zoom you can avoid congregations, but still attend and belong. Because of zoom you can sustain your business and continue medical care. With zoom, learning moved from the classroom to the dining room for all.
The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines.
MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.
Editor's note: This article originally appeared May 14, 2020, and is being shared again as part of RheumNow's "Best of 2020".
Links:
Links:
Dr. John Cush RheumNow( View Tweet)
Links:
Dr. John Cush RheumNow( View Tweet)
Links:
Dr. John Cush RheumNow( View Tweet)
Links:
Dr. John Cush RheumNow( View Tweet)
COVID Vaccine Q & A - Dr Kevin Winthrop Dr. Cush interviews Dr. Kevin Winthrop (OHSU) on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies https://t.co/EJL6hVLnrp https://t.co/XOHk9T04rx
Links:
k dao KDAO2011( View Tweet)
Dr Philip Robinson philipcrobinson( View Tweet)
Links:
